William Murphy
Overland Park, KSNPI 1093721177
Payments from drug & device makers
$1,233,405in general payments, 2019–2025
Across 295 payments — averaging $4181.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$686K
- AbbVie$351K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$150K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$17K
- Sunovion Pharmaceuticals Inc.$17K
- Shire North American Group Inc$11K
- plus $1K from 20 others
$3,941in research payments, 2019–2025
Across 28 payments — averaging $140.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Supernus Pharmaceuticals, Inc.$2K
- Neos Therapeutics, LP$978
- AbbVie$643
General payments by program year
19
21
22
23
24
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 112 | $685,610 |
| AbbVie(2 entities) | 84 | $351,293 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 38 | $150,207 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $17,040 |
| Sunovion Pharmaceuticals Inc. | 4 | $16,779 |
| Shire North American Group Inc | 4 | $11,318 |
| Vanda Pharmaceuticals Inc. | 15 | $254 |
| Bioventus LLC | 1 | $118 |
| Otsuka America Pharmaceutical, Inc. | 6 | $118 |
| Johnson & Johnson | 3 | $95 |
| EMD Serono, Inc. | 1 | $84 |
| Corium, LLC | 3 | $56 |
| Merck | 3 | $56 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $47 |
| Bayer | 2 | $46 |
| Jazz Pharmaceuticals Inc. | 3 | $44 |
| Idorsia Pharmaceuticals US Inc | 2 | $43 |
| Nevro Corp. | 2 | $40 |
| Novo Nordisk | 2 | $39 |
| Upsher-smith Laboratories LLC | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Avanir Pharmaceuticals, Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Ironshore Pharmaceuticals Inc. | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.